160 related articles for article (PubMed ID: 29070849)
1. High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif.
Tsukamoto T; Nakano M; Sato R; Adachi H; Kiyota M; Kawata E; Uoshima N; Yasukawa S; Chinen Y; Mizutani S; Shimura Y; Kobayashi T; Horiike S; Yanagisawa A; Taniwaki M; Tashiro K; Kuroda J
Sci Rep; 2017 Oct; 7(1):14039. PubMed ID: 29070849
[TBL] [Abstract][Full Text] [Related]
2. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
3. Integration of Mutational Signature Analysis with 3D Chromatin Data Unveils Differential AID-Related Mutagenesis in Indolent Lymphomas.
Sepulveda-Yanez JH; Alvarez-Saravia D; Fernandez-Goycoolea J; Aldridge J; van Bergen CAM; Posthuma W; Uribe-Paredes R; Veelken H; Navarrete MA
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884820
[TBL] [Abstract][Full Text] [Related]
4. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.
Huet S; Szafer-Glusman E; Tesson B; Xerri L; Fairbrother WJ; Mukhyala K; Bolen C; Punnoose E; Tonon L; Chassagne-Clément C; Feugier P; Viari A; Jardin F; Salles G; Sujobert P
Am J Hematol; 2017 Jun; 92(6):515-519. PubMed ID: 28247997
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
6. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
[TBL] [Abstract][Full Text] [Related]
7. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
8. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers.
Rogozin IB; Lada AG; Goncearenco A; Green MR; De S; Nudelman G; Panchenko AR; Koonin EV; Pavlov YI
Sci Rep; 2016 Dec; 6():38133. PubMed ID: 27924834
[TBL] [Abstract][Full Text] [Related]
9. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract][Full Text] [Related]
10. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Nakamachi Y; Kumagai S; Ohno H; Tanabe S; Uchida M; Yasuda N
Leukemia; 2004 Apr; 18(4):826-31. PubMed ID: 14990977
[TBL] [Abstract][Full Text] [Related]
11. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
12. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma.
Matolcsy A; Warnke RA; Knowles DM
Ann Oncol; 1997; 8 Suppl 2():119-22. PubMed ID: 9209654
[TBL] [Abstract][Full Text] [Related]
14. Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours.
Karube K; Martínez D; Royo C; Navarro A; Pinyol M; Cazorla M; Castillo P; Valera A; Carrió A; Costa D; Colomer D; Rosenwald A; Ott G; Esteban D; Giné E; López-Guillermo A; Campo E
J Pathol; 2014 Nov; 234(3):423-30. PubMed ID: 25141821
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
Halldórsdóttir AM; Frühwirth M; Deutsch A; Aigelsreiter A; Beham-Schmid C; Agnarsson BA; Neumeister P; Richard Burack W
Leuk Res; 2008 Jul; 32(7):1015-21. PubMed ID: 18180034
[TBL] [Abstract][Full Text] [Related]
16. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival.
Găman AM
Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressors in follicular lymphoma.
Graham C; LeBrun DP
Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
[TBL] [Abstract][Full Text] [Related]
19. Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications.
van den Brand M; Rijntjes J; Hebeda KM; Menting L; Bregitha CV; Stevens WB; van der Velden WJ; Tops BB; van Krieken JH; Groenen PJ
Histopathology; 2017 Jan; 70(2):174-184. PubMed ID: 27297871
[TBL] [Abstract][Full Text] [Related]
20. Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.
Cheung KJ; Johnson NA; Affleck JG; Severson T; Steidl C; Ben-Neriah S; Schein J; Morin RD; Moore R; Shah SP; Qian H; Paul JE; Telenius A; Relander T; Lam W; Savage K; Connors JM; Brown C; Marra MA; Gascoyne RD; Horsman DE
Cancer Res; 2010 Nov; 70(22):9166-74. PubMed ID: 20884631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
